Analystreport

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its price target raised by analysts at Morgan Stanley from $49.00 to $50.00. They now have an "underweight" rating on

Ionis Pharmaceuticals, Inc.  (IONS) 
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ionispharma.com